"Carcinoma, Lobular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of BREAST CANCER where the abnormal malignant cells form in the lobules, or milk-producing glands, of the breast.
| Descriptor ID |
D018275
|
| MeSH Number(s) |
C04.557.470.200.025.305 C04.557.470.615.305 C04.588.180.437 C17.800.090.500.437
|
| Concept/Terms |
Carcinoma, Lobular- Carcinoma, Lobular
- Carcinomas, Lobular
- Lobular Carcinoma
- Lobular Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Lobular".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Lobular".
This graph shows the total number of publications written about "Carcinoma, Lobular" by people in this website by year, and whether "Carcinoma, Lobular" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 1 | 2 | 3 |
| 2001 | 2 | 0 | 2 |
| 2002 | 4 | 2 | 6 |
| 2003 | 3 | 2 | 5 |
| 2004 | 5 | 2 | 7 |
| 2005 | 3 | 4 | 7 |
| 2006 | 8 | 3 | 11 |
| 2007 | 3 | 4 | 7 |
| 2008 | 7 | 3 | 10 |
| 2009 | 5 | 4 | 9 |
| 2010 | 9 | 4 | 13 |
| 2011 | 12 | 2 | 14 |
| 2012 | 11 | 2 | 13 |
| 2013 | 3 | 3 | 6 |
| 2014 | 11 | 4 | 15 |
| 2015 | 11 | 1 | 12 |
| 2016 | 5 | 1 | 6 |
| 2017 | 9 | 1 | 10 |
| 2018 | 1 | 1 | 2 |
| 2019 | 7 | 0 | 7 |
| 2020 | 4 | 2 | 6 |
| 2021 | 2 | 1 | 3 |
| 2022 | 4 | 0 | 4 |
| 2023 | 4 | 0 | 4 |
| 2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Lobular" by people in Profiles.
-
Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2025 Feb; 32(2):922-930.
-
Breast Radiologists' Perceptions on the Detection and Management of Invasive Lobular Carcinoma: Most Agree Imaging Beyond Mammography Is Warranted. J Breast Imaging. 2024 Apr 01; 6(2):157-165.
-
Immediate and delayed risk of breast cancer associated with classic lobular carcinoma in situ and its variants. Breast Cancer Res Treat. 2024 Jun; 205(3):545-554.
-
Efficacy of Single-Agent Chemotherapy in Endocrine Therapy-Refractory Metastatic Invasive Lobular Carcinoma. Oncologist. 2024 Mar 04; 29(3):213-218.
-
Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management. Ann Surg Oncol. 2024 Apr; 31(4):2224-2230.
-
Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes. Breast Cancer Res Treat. 2023 Nov; 202(2):367-375.
-
Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinoma. Eur J Cancer. 2023 09; 191:113250.
-
HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series. Breast Cancer Res Treat. 2023 Jun; 199(2):349-354.
-
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer. Cancer Res. 2022 10 17; 82(20):3673-3686.
-
Natural History and Characteristics of ERBB2-mutated Hormone Receptor-positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case-control Study from AACR Project GENIE. Clin Cancer Res. 2022 05 13; 28(10):2118-2130.